Department of Cardiothoracic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Division of Cardiology, The Heart Institute, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.
J Thorac Cardiovasc Surg. 2022 Dec;164(6):2019-2031. doi: 10.1016/j.jtcvs.2021.10.082. Epub 2022 Mar 1.
Significant renal insufficiency is identified as a risk factor for post-transplantation mortality in pediatric heart transplant recipients. This study evaluates simultaneous heart-kidney transplantation listing outcomes compared with heart transplant for pediatric candidates with significant renal insufficiency.
The United Network for Organ Sharing registry was searched for patients (January 1987 to March 2020) who were simultaneously listed for a heart-kidney transplantation or for heart transplant with significant renal insufficiency at the time of listing. Significant renal insufficiency was defined as needing dialysis or having a low estimated glomerular filtration rate (<40 mL/min). Survival was calculated using Kaplan-Meier analysis.
A total of 427 cases were identified; 109 were listed for heart-kidney transplantation, and 318 were listed for heart transplant alone. Median time on the waitlist was 101 days (interquartile range, 28-238) for heart-kidney transplantation listings compared with 39 days (14-86) and 23.5 days (6-51) for heart transplant recipients with a low estimated glomerular filtration rate (P = .002) or on dialysis (P < .001), respectively. Of all heart-kidney transplantation listings, 66% (n = 71) received a transplant compared with 54% (n = 173) of heart transplantation with significant renal insufficiency (P = .005) with a mean survival of 14.6 years (12.7-16.4 years) for heart transplant without significant renal insufficiency at transplantation and 7.6 years (5.4-9.9 years) for heart transplant with significant renal insufficiency at transplantation. At 1 year after listing, 69% of heart-kidney transplantation listed recipients were alive, compared with 51% of heart transplant listed recipients (P = .029). Heart-kidney transplantation recipients had better 1-year post-transplantation survival (86%) than heart transplantation with significant renal insufficiency at transplant (66%) (P = .001). There was no significant difference in the 1- and 5-year survivals of those undergoing heart transplantation listed with significant renal insufficiency but no significant renal insufficiency at the time of transplant (89% and 78%) and heart-kidney transplantation recipients (86% and 81%; P = .436).
Pediatric candidates with significant renal insufficiency listed for heart-kidney transplantation have superior waitlist and post-transplantation outcomes compared with those listed for heart transplant alone. Patients with significant renal insufficiency should be listed for heart-kidney transplantation, however; if their renal function improves significantly, heart transplant alone appears judicious.
严重肾功能不全被认为是儿科心脏移植受者移植后死亡的一个危险因素。本研究评估了与同时存在严重肾功能不全的儿科患者进行单纯心脏移植相比,同时进行心脏-肾脏移植的列入名单的结果。
检索 1987 年 1 月至 2020 年 3 月期间美国器官共享网络登记册中同时被列入心脏-肾脏移植或心脏移植名单且在列入名单时存在严重肾功能不全的患者。严重肾功能不全定义为需要透析或肾小球滤过率估计值较低(<40 mL/min)。使用 Kaplan-Meier 分析计算存活率。
共确定了 427 例患者;109 例被列入心脏-肾脏移植名单,318 例被列入单纯心脏移植名单。与低估计肾小球滤过率(<40 mL/min)(P = 0.002)或透析患者(P < 0.001)相比,心脏-肾脏移植名单中位等待时间分别为 101 天(四分位距,28-238)和 39 天(14-86)和 23.5 天(6-51)。在所有心脏-肾脏移植名单中,66%(n = 71)接受了移植,而严重肾功能不全的心脏移植名单中,54%(n = 173)接受了移植(P = 0.005),其中无严重肾功能不全的心脏移植的平均存活时间为 14.6 年(12.7-16.4 年),而严重肾功能不全的心脏移植为 7.6 年(5.4-9.9 年)。在移植时无严重肾功能不全的心脏移植患者中,1 年后有 69%的患者存活,而在移植时存在严重肾功能不全的心脏移植患者中,有 51%的患者存活(P = 0.029)。心脏-肾脏移植患者的 1 年移植后生存率(86%)优于移植时存在严重肾功能不全的心脏移植患者(66%)(P = 0.001)。在移植时存在严重肾功能不全但无显著肾功能不全的患者(89%和 78%)和心脏-肾脏移植患者(86%和 81%)的 1 年和 5 年生存率无显著差异(P = 0.436)。
与单独进行心脏移植相比,同时进行心脏-肾脏移植的严重肾功能不全儿科患者在等待名单和移植后结果方面具有优势。然而,严重肾功能不全患者应列入心脏-肾脏移植名单;如果他们的肾功能显著改善,单独进行心脏移植似乎是合理的。